Treatment options for neuroendocrine tumors (NETs) and carcinomas (NECs) are
expanding. Early-phase studies have shown preliminary evidence of the antitumor activity of …

Gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs) represents a various
family of rare tumours. Surgery is the first choice in GEP-NENs patients with localized …

Background Gastroenteropancreatic neuroendocrine tumours (GEP NETs) are relatively
uncommon tumours that occur anywhere within the gastrointestinal tract. The prevalence of …

In recent years, there have been important scientific advances in the biologic
characterization of neuroendocrine neoplasms and in their treatment. This review will …

The molecular events leading to gastroenteropancreatic neuroendocrine tumor (GEP-NET)
formation are largely unknown. Over the past decades, systemic chemotherapies have been …

Patients with rare tumors represent a diagnostic and therapeutic challenge for non-
specialized physicians, surgeons and other medical doctors. Whereas several specialized …

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are more common than
previously thought and second only to colorectal cancers as the most prevalent …

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a rare and heterogeneous
class of neoplasms. While surgical resection is the mainstay of treatment, non-surgical …

Although neuroendocrine neoplasms (NEN) were once thought to be rare and mostly
“benign” diseases, they are now being redefined in light of recently discovered molecular …

Introduction: Gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are unique and
complex neoplasms, exhibiting a wide spectrum of diverse clinical behaviors. The …